All In MedTech

Device Trial Radar · NCT05186740

ProVee Urethral Expander System IDE Study (ProVIDE)

The ProVee Urethral Expander System Clinical Study

Last checked: Nov 19, 2026Latest source record: Jul 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registryPivotal-lookingRandomized with 221 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

221

Actual

Start

Jun 9, 2022

Primary completion

Mar 15, 2024

Study completion Dec 2028

Sponsor

Lead sponsor
ProVerum MedicalNot on our public-company list
Sponsor type
Industry
First posted
Jan 11, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
Male only, from 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary obstruction related to benign prostatic hyperplasia (BPH).

Conditions

  • BPH With Symptomatic Lower Urinary Tract Symptoms

Interventions

  • ProVee Urethral Expander SystemDevice

    ProVee Expander is placed in prostatic urethra to relieve obstruction due to BPH.

  • Urethral Access SheathProcedure

    The Urethral Access Sheath is introduced into the prostatic urethra to simulate the placement of the ProVee Expander.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety: Adverse Events (Time Frame: Procedure to 12 Months)Time frame: Procedure - 12 months
  2. Safety: Number of Participants With Need for Urinary Catheterization (Time Frame: >7 Days Post Procedure)Time frame: 7 days post treatment through to 12 months
  3. Effectiveness: Number of Participants With Reduction in BPH Symptoms Compared to Sham (Time Frame: Procedure to 3 Months)Time frame: Procedure to 3 months

1 more outcomes with a free account

Locations

16 sites in 3 countries. Site status is shown where the registry gives one.

  • Golden State Urology

    Sacramento, California

  • Urological Research Network Corp

    Hialeah, Florida

  • Advanced Urology Institute

    Palm Coast, Florida

13 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.